| Literature DB >> 35261453 |
Bhavika Gandhi1, Deborah Jebakumar2, Matthew Nickell3, Mohanram Narayanan1.
Abstract
Acute kidney injury is common among hospitalized COVID-19 patients, with the incidence ranging from 0.5% to 80%, due to diverse pathologies including acute tubular injury, collapsing glomerulopathy, and thrombotic microangiopathy (TMA). While macrovascular thrombosis is common in these individuals, the frequent finding of extensive microvascular thromboses in several series and case reports raises the possibility of thrombotic microangiopathy (TMA) being a contributing factor in the thrombotic and multiorgan complications of the disease. TMA has been described as either the primary finding or in concert with other pathologic findings in COVID-19 patients and carries a poor prognosis, with all patients requiring dialysis. We present a case of TMA with retinal injury and bowel perforation in addition to pulmonary and renal manifestations.Entities:
Keywords: COVID-19; dialysis; eculizumab; thrombotic microangiopathy
Year: 2021 PMID: 35261453 PMCID: PMC8865316 DOI: 10.1080/08998280.2021.1997054
Source DB: PubMed Journal: Proc (Bayl Univ Med Cent) ISSN: 0899-8280